Preparation and in vitro evaluation of carrier erythrocytes for RES-targeted delivery of interferon-alpha 2b
- PMID: 17512685
- DOI: 10.1016/j.ijpharm.2007.04.001
Preparation and in vitro evaluation of carrier erythrocytes for RES-targeted delivery of interferon-alpha 2b
Abstract
Carrier erythrocytes is one of the most promising systemic drug delivery systems investigated in recent decades. In this study, human erythrocytes have been loaded with interferon-alpha 2b (IFN) with the aim to benefit the reticuloendothelial system (RES) targeting potential of the carrier cells. Hypotonic preswelling method was used for drug loading in erythrocytes and the entire loading procedure was evaluated and validated. The loaded amount, entrapment efficiency and cell recovery of the loading procedure were 2906.33+/-588.35IU/0.1ml, 14.53+/-2.94%, and 83.61+/-0.49%, respectively, all being practically feasible. The carrier erythrocytes were characterized in vitro in terms of their drug release kinetics, hematological indices, particle size distribution, SEM analysis, and osmotic and turbulence fragility. IFN release from carrier cells was a relatively rapid process in comparison to the cell lysis kinetics, which is unusual considering the whole body of data published on this delivery system and other protein drugs, so far. All the tested in vitro characteristics showed significant, sometimes notable changes upon drug loading procedure, both with and without the drug.
Similar articles
-
Preparation and in vitro characterization of carrier erythrocytes for vaccine delivery.Int J Pharm. 2007 Jun 29;338(1-2):70-8. doi: 10.1016/j.ijpharm.2007.01.025. Epub 2007 Jan 20. Int J Pharm. 2007. PMID: 17317049
-
In vitro characterization of human intact erythrocytes loaded by enalaprilat.Drug Deliv. 2001 Oct-Dec;8(4):223-30. doi: 10.1080/107175401317245903. Drug Deliv. 2001. PMID: 11757780
-
Preparation and in-vitro characterization of tramadol-loaded carrier erythrocytes for long-term intravenous delivery.J Pharm Pharmacol. 2011 Mar;63(3):322-32. doi: 10.1111/j.2042-7158.2010.01207.x. Epub 2010 Dec 22. J Pharm Pharmacol. 2011. PMID: 21749379
-
Carrier erythrocytes: an overview.Drug Deliv. 2003 Jan-Mar;10(1):9-20. doi: 10.1080/713840329. Drug Deliv. 2003. PMID: 12554359 Review.
-
Erythrocyte-based drug delivery.Expert Opin Drug Deliv. 2005 Mar;2(2):311-22. doi: 10.1517/17425247.2.2.311. Expert Opin Drug Deliv. 2005. PMID: 16296756 Review.
Cited by
-
Autologous Red Blood Cell Delivery of Betamethasone Phosphate Sodium for Long Anti-Inflammation.Pharmaceutics. 2018 Dec 18;10(4):286. doi: 10.3390/pharmaceutics10040286. Pharmaceutics. 2018. PMID: 30567356 Free PMC article.
-
Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application.Acta Pharm Sin B. 2019 Jul;9(4):675-689. doi: 10.1016/j.apsb.2019.01.011. Epub 2019 Jan 24. Acta Pharm Sin B. 2019. PMID: 31384529 Free PMC article. Review.
-
Cyclic arginine-glycine-aspartic acid-modified red blood cells for drug delivery: Synthesis and in vitro evaluation.J Pharm Anal. 2022 Apr;12(2):324-331. doi: 10.1016/j.jpha.2021.06.003. Epub 2021 Jun 12. J Pharm Anal. 2022. PMID: 35582403 Free PMC article.
-
Drug-loaded erythrocytes: on the road toward marketing approval.Drug Des Devel Ther. 2016 Feb 11;10:665-76. doi: 10.2147/DDDT.S96470. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 26929599 Free PMC article. Review.
-
Red blood cells: a potential delivery system.J Nanobiotechnology. 2023 Aug 22;21(1):288. doi: 10.1186/s12951-023-02060-5. J Nanobiotechnology. 2023. PMID: 37608283 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources